{
  "id": 5356380,
  "title": "Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data",
  "url": "https://urgent.news/2026/09/03/pfizer-shares-adc-rights-with-medicus-revmed-updates-lung-cancer-data",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-03T15:19:01.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/pfizer-shares-adc-rights-with-medicus-revmed-updates-lung-cancer-data/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus, news about Novartis. 🤝 Pfizer turns over ADC: The New York pharma is giving Medicus Pharma co-development rights to a CD228-targeted antibody-drug conjugate known as PF-08046031, a Seagen-derived asset that it ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}